Page last updated: 2024-10-26

pentetic acid and Neurofibromatosis 1

pentetic acid has been researched along with Neurofibromatosis 1 in 12 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Neurofibromatosis 1: An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).

Research Excerpts

ExcerptRelevanceReference
"Our case occurred in association with neurofibromatosis type 1 and in the absence of an identified primary tumor."1.39MIBG superscan of metastatic paraganglioma occurring with neurofibromatosis type 1. ( Barron, BJ; Harrison, CE, 2013)
"Purely capillary hemangiomas have transient early intense activity while purely cavernous hemangiomas display no early activity but are well visualized on delayed scintigraphic images."1.28Scintigraphic differentiation of congenital soft-tissue extremity enlargement with Tc-99m DTPA. ( Harcke, HT; Harris, L; Mandell, GA; Scott, CI; Sharkey, C, 1989)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's4 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harrison, CE1
Barron, BJ1
Parazzini, C1
Triulzi, F1
Bianchini, E1
Agnetti, V1
Conti, M1
Zanolini, C1
Maninetti, MM1
Rossi, LN1
Scotti, G1
Maini, CL1
Cioffi, RP1
Tofani, A1
Sciuto, R1
Fontana, M1
Carapella, CM1
Crecco, M1
Van Es, S1
North, KN1
McHugh, K1
De Silva, M1
Kurosaki, Y1
Kuramoto, K1
Itai, Y1
Mandell, GA3
Scott, CI1
Harcke, HT3
Sharkey, C3
Harris, L1
Dolan, KD1
Yuh, WT1
Siddiqui, AR1
Brooks, KM2
MacEwen, GD2
Ida, M1
Mashima, Y1
Mori, Y1
Kawakami, K1
Kondoh, H1
Kaminsky, S1
Schulz, B1
Herrick, WC1

Other Studies

12 other studies available for pentetic acid and Neurofibromatosis 1

ArticleYear
MIBG superscan of metastatic paraganglioma occurring with neurofibromatosis type 1.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:6

    Topics: 3-Iodobenzylguanidine; Female; Humans; Middle Aged; Neurofibromatosis 1; Octreotide; Paraganglioma;

2013
Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:8

    Topics: Adolescent; Child; Child, Preschool; Contrast Media; Cranial Nerve Neoplasms; Drug Combinations; Fem

1995
Indium-111 octreotide scintigraphy in neurofibromatosis.
    European journal of nuclear medicine, 1995, Volume: 22, Issue:3

    Topics: Adolescent; Child; Diagnosis, Differential; Female; Humans; Indium Radioisotopes; Male; Middle Aged;

1995
MRI findings in children with neurofibromatosis type 1: a prospective study.
    Pediatric radiology, 1996, Volume: 26, Issue:7

    Topics: Brain; Brain Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; M

1996
Delayed enhancement of peripheral zone of neurofibromas at magnetic resonance imaging.
    European radiology, 1996, Volume: 6, Issue:1

    Topics: Adult; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magn

1996
Scintigraphic differentiation of congenital soft-tissue extremity enlargement with Tc-99m DTPA.
    Skeletal radiology, 1989, Volume: 18, Issue:1

    Topics: Child; Extremities; Female; Hemangioma; Humans; Lipoma; Male; Neurofibromatosis 1; Organometallic Co

1989
Gadolinium-enhanced facial nerves: accompanying bilateral acoustic tumors in patient with neurofibromatosis.
    The Annals of otology, rhinology, and laryngology, 1989, Volume: 98, Issue:9

    Topics: Adult; Contrast Media; Facial Nerve; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging

1989
Localization of technetium-99m DTPA in neurofibroma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986, Volume: 27, Issue:1

    Topics: Child; Female; Humans; Lumbosacral Region; Neurofibromatosis 1; Pentetic Acid; Radionuclide Imaging;

1986
SPECT imaging of para-axial neurofibromatosis with technetium-99m DTPA.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1987, Volume: 28, Issue:11

    Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Neurofibromatosis 1; Organometalli

1987
[Evaluation of Tc-99m DTPA as tumor seeking agents for neurofibromatosis].
    Kaku igaku. The Japanese journal of nuclear medicine, 1988, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Child; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neurilemmoma; Ne

1988
[Visualization of multiple neurofibromas using gadolinium-DTPA assisted MRT: a case report].
    Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie, 1988, Volume: 41, Issue:12

    Topics: Adult; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Neurof

1988
Neurofibromas: location by scanning with Tc-99m DTPA. Work in progress.
    Radiology, 1985, Volume: 157, Issue:3

    Topics: Adolescent; Adult; Child; Female; Humans; Male; Neurofibromatosis 1; Pentetic Acid; Prospective Stud

1985